Amgen stock: Piper Sandler sets USD 457 target pre-market
Published on 10/21/2026 at 08:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst action and November agenda
- Piper Sandler analyst David Amsellem set a USD 457.00 price target for Amgen on October 20, 2026.
- Amgen's next earnings conference call is scheduled for November 3, 2026.
- Amgen stock trades pre-market at EUR 391.93 at 8:32 a.m. CEST at Lang & Schwarz on October 21, 2026.
On October 20, 2026, Piper Sandler analyst David Amsellem reiterated a Buy rating and set a USD 457.00 price target for Amgen, according to Markets Insider. Amgen stock trades pre-market at EUR 391.93 at 8:32 a.m. CEST at Lang & Schwarz on October 21, 2026.
Analyst rating and target
Piper Sandler's David Amsellem maintained a Buy rating on Amgen and assigned a USD 457.00 price target on October 20, 2026. The report also cited Amgen's second-quarter revenue of USD 10.05 billion, according to Markets Insider.
Amgen and the upcoming calendar
Amgen develops medicines for patients with serious illnesses through a science-based biotechnology business, according to its investor-relations site. The company lists its third-quarter 2026 earnings conference call for Tuesday, November 3, 2026, at 1:30 p.m. Pacific Time on the same page.
The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Amgen stock.
Market context: Market report S&P 500.
